Amneal Pharmaceuticals, Inc. (AMRX)
$17.78-0.73%Close
SELLBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $5.7B
- Avg volume
- 1.9M
- Beta
- 1.25
- P/E (TTM)
- 35.74
- Short % float
- 5.09%
- Days to cover
- 4.6
- SI change
- +2.5%
- 1W
- -3.47%
- 1M
- -0.78%
- 3M
- +43.16%
- YTD
- +40.44%
- vs SPY 1W
- -2.28%
- vs SPY 1M
- -4.10%
- vs SPY 3M
- +40.76%
- vs SPY YTD
- +28.69%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- BDTXBUYBlack Diamond Therapeutics, Inc.RECOVERYQ -6$2.15-2.71%
- ALKSSELLAlkermes plcBEARQ 6$48.87+1.12%
- OFIXSELLOrthofix Medical Inc.CRISISQ 3$9.79-2.20%
- ONCOSELLOnconetix, Inc.CRISISQ 6$0.66+1.54%
- ADILBUYAdial Pharmaceuticals, Inc.RECOVERYQ -14$5.40-13.18%
- ICUIBUYICU Medical, Inc.BULLQ 22$182.55-0.16%
- NIVFSELLNewGenIvf Group LimitedCRISISQ -32$0.49-15.52%
- CNSPBUYCNS Pharmaceuticals, Inc.RECOVERYQ -27$5.94+1.89%
- BDXBUYBecton, Dickinson and CompanyBULLQ 18$190.74-0.66%
- MCKBUYMcKesson CorporationRECOVERYQ 12$873.79+1.73%
- SRTABUYStrata Critical Medical, Inc.RECOVERYQ 1$5.97-4.33%
- IMRXBUYImmuneering CorporationRECOVERYQ -3$5.18-2.26%
Industry peers
FMP comparable companies · ranked by market cap
- LNTHSELLLantheus Holdings, Inc.$6.6BBEARQ 31$100.80+0.83%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.9BCRISISQ 38$96.72+0.43%
- DYNBUYDyne Therapeutics, Inc.$4.9BBULLQ 8$25.99-0.42%
- INDVSELLIndivior Pharmaceuticals Inc$4.5BBEARQ 20$36.18-1.87%
- NVSTBUYEnvista Holdings Corp$4.4BBEARQ 3$27.34+0.51%
- TLXBUYTelix Pharmaceuticals Limited$4.0BBULLQ -3$11.68+3.09%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.6BRECOVERYQ 27$45.11-1.61%
- BHCBUYBausch Health Companies Inc.$2.5BRECOVERYQ 1$6.68+3.73%
- PRGOBUYPerrigo Company plc$2.0BRECOVERYQ 1$14.27+0.14%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 19
- VALUE
- 10
- GROWTH
- 45
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-196.1%
REV YoY-
ROE-326.8%
EPS YoY-
ROA4.2%
GROSS39
OP13
NET5
[VALUATION]
P/E TTM35.74
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.61
P/B171.86
P/FCF-
EV/EBITDA12.79
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E8453.73
ALTMAN Z-
CURR RATIO2.20
ND/EBITDA-
BETA1.25
